# Randomized Pilot Study for the Treatment of Cutaneous Leiomyomas With Botulinum Toxin

> **NCT00971620** · PHASE2 · COMPLETED · sponsor: **National Cancer Institute (NCI)** · enrollment: 18 (actual)

## Conditions studied

- Cutaneous Leiomyomas
- Hereditary Leiomyomatosis and Renal Cell Cancer

## Interventions

- **BIOLOGICAL:** Botulinum toxin type A
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT00971620
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-11-17
- **Primary completion:** 2014-01-09
- **Final completion:** 2016-10-12
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2017-04-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00971620

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00971620, "Randomized Pilot Study for the Treatment of Cutaneous Leiomyomas With Botulinum Toxin". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00971620. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*